|
FDA Gives Go-Ahead to Drugs for Hypertension, ITP Treatment
Two pharmaceutical companies announced late Friday they received FDA approval for their drugs, one aimed at hypertension, the other for idiopathic thrombocytopenic purpura (ITP).
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives